Spleen involvement in women with ovarian cancer.
The aim of this study was to determine the prognostic factors of spleen metastases in ovarian cancer. A retrospective chart review was conducted and ten patients with spleen metastases were evaluated. Eight were Stage III, one Stage I and one Stage IV. One patient had a spleen metastasis at the time of ovarian cancer diagnosis, whereas, the remaining patients 23.4+12 months after ovarian cancer diagnosis. Spleen involvement is a late complication that rarely occurs in ovarian cancer and confers a poor prognosis. The interval time between ovarian cancer diagnosis and appereance of spleen involvement is the most important prognostic factor.
Cormio
G
G
Department of Obstetrics and Gynecology, Gynecologic Oncology Unit, University of Bari, Bari, Italy.
Loizzi
V
V
Carriero
C
C
Putignano
G
G
Selvaggi
L
L
D000328:Adult; D002277:Carcinoma / Q000401:mortality / Q000556:secondary* / Q000601:surgery; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D011379:Prognosis; D013160:Splenic Neoplasms / Q000556:secondary* / Q000601:surgery; D013534:Survival